Skip to main content
Caplight Logo









Ategenos Pharmaceuticals

Ategenos Pharmaceuticals

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://ategenosrx.com/

Company Overview

Ategenos Pharmaceuticals is a PharmaTech company that develops the SmartPatch platform, an advanced transdermal system designed to provide sustained drug delivery with real-time medication adherence monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

transdermal drug deliverymedication adherencesmart patchconnected healthdigital medicinehealth IoTdrug reformulationreal-world evidencelifecycle management505(b)(2)patient monitoringpharma techremote patient monitoringRPMmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ategenos Pharmaceuticals Comparables

Compare Ategenos Pharmaceuticals with similar companies based on industry and business-model similarity.

Ategenos Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Remagine Labs
80%
Medicsen
74%
PillSafe Technologies
69%

Ategenos Pharmaceuticals Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Ategenos Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Ategenos Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ategenos Pharmaceuticals's valuation, stock price, and market status.

Is Ategenos Pharmaceuticals a public or private company?

Ategenos Pharmaceuticals is a private company.

What is the current stock price of Ategenos Pharmaceuticals?

Ategenos Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Ategenos Pharmaceuticals worth (valuation)?

Valuation information for Ategenos Pharmaceuticals is not publicly available.

Can I buy Ategenos Pharmaceuticals stock?

Ategenos Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ategenos Pharmaceuticals's last funding round?

Funding round information for Ategenos Pharmaceuticals is not publicly available.

Who are the main investors in Ategenos Pharmaceuticals?

Investor information for Ategenos Pharmaceuticals is not publicly disclosed.

Will Ategenos Pharmaceuticals IPO soon?

No public IPO plans have been announced for Ategenos Pharmaceuticals.

How can I track Ategenos Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ategenos Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?